Aidi Pharmaceuticals: Termination of the company's 2026 simplified issuance of A-shares to specific targets

NightAirdropper · 2026-03-04T14:23:06+00:00

Aidi Pharmaceutical announced the decision to terminate the issuance of A-shares to specific targets in 2026. The relevant resolution was approved at the board of directors meeting on March 2nd, without the need for shareholder approval. Meanwhile, former Deputy Minister of Finance Zhu Guangyao predicted that China's nominal GDP growth rate could reach 7% during the "14th Five-Year Plan" period.

NightAirdropper

2026-03-04 14:23:06

Abstract generation in progress

Everyday Economic News AI Express, on the evening of March 2nd, announced that Jiangsu Aidi Pharmaceutical Group Co., Ltd. held the 13th meeting of the third board of directors on February 28, 2026, to review and approve the “Proposal on Terminating the Company’s 2026 Simplified Issuance of A-shares to Specific Targets” and other related proposals. The company has decided to terminate the simplified issuance of A-shares to specific targets in 2026. This matter does not need to be submitted to the shareholders’ meeting for approval.

Everyday Headline (nbdtoutiao)—Exclusive interview with Zhu Guangyao, former Vice Minister of Finance: During the 14th Five-Year Plan period, China’s nominal GDP growth rate is expected to reach about 7%, with the total economic output potentially exceeding 36 trillion yuan.

(Reporter Wang Xiaobo)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Proceed at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes